BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8391066)

  • 1. Treatment of primary hepatobiliary cancers with conformal radiation therapy and regional chemotherapy.
    Robertson JM; Lawrence TS; Dworzanin LM; Andrews JC; Walker S; Kessler ML; DuRoss DJ; Ensminger WD
    J Clin Oncol; 1993 Jul; 11(7):1286-93. PubMed ID: 8391066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment of colorectal liver metastases with conformal radiation therapy and regional chemotherapy.
    Robertson JM; Lawrence TS; Walker S; Kessler ML; Andrews JC; Ensminger WD
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):445-50. PubMed ID: 7751185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
    Ben-Josef E; Normolle D; Ensminger WD; Walker S; Tatro D; Ten Haken RK; Knol J; Dawson LA; Pan C; Lawrence TS
    J Clin Oncol; 2005 Dec; 23(34):8739-47. PubMed ID: 16314634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of hepatic artery fluorodeoxyuridine and conformal radiation therapy for primary hepatobiliary cancers.
    Robertson JM; Lawrence TS; Andrews JC; Walker S; Kessler ML; Ensminger WD
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):325-30. PubMed ID: 9069303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I trial of hepatic arterial bromodeoxyuridine and conformal radiation therapy for patients with primary hepatobiliary cancers or colorectal liver metastases.
    Robertson JM; McGinn CJ; Walker S; Marx MV; Kessler ML; Ensminger WD; Lawrence TS
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1087-92. PubMed ID: 9392548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies.
    Dawson LA; McGinn CJ; Normolle D; Ten Haken RK; Walker S; Ensminger W; Lawrence TS
    J Clin Oncol; 2000 Jun; 18(11):2210-8. PubMed ID: 10829040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium.
    Marks LB; Garst J; Socinski MA; Sibley G; Blackstock AW; Herndon JE; Zhou S; Shafman T; Tisch A; Clough R; Yu X; Turrisi A; Anscher M; Crawford J; Rosenman J;
    J Clin Oncol; 2004 Nov; 22(21):4329-40. PubMed ID: 15514374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma].
    Zhou ZH; Liu LM; Cheng WW; Meng ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):222-6. PubMed ID: 16875612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased multimodality treatment options has improved survival for Hepatocellular carcinoma but poor survival for biliary tract cancers remains unchanged.
    Alabraba E; Joshi H; Bird N; Griffin R; Sturgess R; Stern N; Sieberhagen C; Cross T; Camenzuli A; Davis R; Evans J; O'Grady E; Palmer D; Diaz-Nieto R; Fenwick S; Poston G; Malik H
    Eur J Surg Oncol; 2019 Sep; 45(9):1660-1667. PubMed ID: 31014988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy of transcatheter arterial chemoembolisation and three-dimensional conformal radiotherapy for hepatocellular carcinoma.
    Zhou ZH; Liu LM; Chen WW; Men ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
    Br J Radiol; 2007 Mar; 80(951):194-201. PubMed ID: 17038412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
    Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
    J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma].
    Wu DH; Chen LH
    Ai Zheng; 2004 Jul; 23(7):825-8. PubMed ID: 15248921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial.
    Socinski MA; Morris DE; Halle JS; Moore DT; Hensing TA; Limentani SA; Fraser R; Tynan M; Mears A; Rivera MP; Detterbeck FC; Rosenman JG
    J Clin Oncol; 2004 Nov; 22(21):4341-50. PubMed ID: 15514375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cancers involving the liver and porta hepatis with external beam irradiation and intraarterial hepatic fluorodeoxyuridine.
    Lawrence TS; Dworzanin LM; Walker-Andrews SC; Andrews JC; Ten Haken RK; Wollner IS; Lichter AS; Ensminger WD
    Int J Radiat Oncol Biol Phys; 1991 Mar; 20(3):555-61. PubMed ID: 1847363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer.
    Bartlett DL; Libutti SK; Figg WD; Fraker DL; Alexander HR
    Surgery; 2001 Feb; 129(2):176-87. PubMed ID: 11174711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer.
    Mohiuddin M; Chen E; Ahmad N
    J Clin Oncol; 1996 Mar; 14(3):722-8. PubMed ID: 8622017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformal high-dose radiation plus intraarterial floxuridine for hepatic cancer.
    Lawrence TS; Kessler ML; Robertson JM
    Oncology (Williston Park); 1993 Oct; 7(10):51-7; discussion 57-8, 63. PubMed ID: 8251308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic intra-arterial interferon alpha 2b-based immunotherapy combined with 5-fluorouracil (5-FU)-based systemic chemotherapy for patients with hepatocellular carcinoma (HCC) not responsive and/or not eligible for conventional treatments: a pilot study.
    Vitale FV; Romeo P; Vasta F; Panebianco V; Calì S; Rotondo S; Ferraù F; La Greca M
    Anticancer Res; 2007; 27(6B):4077-81. PubMed ID: 18225574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.